Cary Street Partners Investment Advisory’s DexCom DXCM Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,153	Closed	-$108K	–	923
2023 Q3	$108K	Buy	1,153 +115	+11%	+$13K	0.01%	690
2023 Q2	$133K	Buy	1,038 +300	+41%	+$36.3K	0.01%	610
2023 Q1	$85.7K	Sell	738 -14	-2%	-$1.57K	0.01%	628
2022 Q4	$85.2K	Buy	+752	New	+$82.6K	0.01%	620
2020 Q4	–	Sell	-400	Closed	-$41K	–	487
2020 Q3	$41K	Buy	+400	New	+$41.8K	0.01%	520

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cary Street Partners Investment Advisory's DXCM Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of DexCom (DXCM) in Q4 2023, closing a stake of 1,153 shares — an estimated $108K sold.

Cary Street Partners Investment Advisory first reported a position in DXCM in Q3 2020 and held it in 5 quarters. The position peaked at $133K in Q2 2023. 975 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

Cary Street Partners Investment Advisory reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
Cary Street Partners Investment Advisory sold 1,153 DexCom shares in Q4 2023, an estimated $108K.
Cary Street Partners Investment Advisory first reported a position in DexCom in Q3 2020 and held it in 5 quarters.
Cary Street Partners Investment Advisory's DexCom position peaked at $133K in Q2 2023.
975 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.